Last reviewed · How we verify
Central retinal vein occlusion with macular edema
Approved treatments
- Decadron · Generic (originally Merck)
- Eylea · Texas Retina Associates
- Lucentis · Santen Inc.
- Vegf Trap · Regeneron
- BYOOVIZ · SAMSUNG BIOEPIS CO LTD
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Central retinal vein occlusion with macular edema patent landscape — cliff calendar, originator estates, attackable patents
- Central retinal vein occlusion with macular edema treatment landscape brief
- Central retinal vein occlusion with macular edema treatment updates RSS
Frequently asked questions about Central retinal vein occlusion with macular edema
What drugs treat Central retinal vein occlusion with macular edema?
Tracked treatments include Decadron, Eylea, Lucentis, Vegf Trap, BYOOVIZ.
What is the treatment for Central retinal vein occlusion with macular edema?
Standard treatment for Central retinal vein occlusion with macular edema includes Decadron, Eylea, Lucentis, Vegf Trap, BYOOVIZ. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Central retinal vein occlusion with macular edema patent cliff · Central retinal vein occlusion with macular edema CI report
- Treatment: Decadron · Generic (originally Merck)
- Treatment: Eylea · Texas Retina Associates
- Treatment: Lucentis · Santen Inc.
- Treatment: Vegf Trap · Regeneron
- Treatment: BYOOVIZ · SAMSUNG BIOEPIS CO LTD
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing